European Heart Journal Advance Access originally published online on August 8, 2005
European Heart Journal 2006 27(8):905-912; doi:10.1093/eurheartj/ehi441
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
The role of non-invasive imaging in the risk stratification of asymptomatic diabetic subjects
1Cardiac Imaging and Research Centre, Wellington Hospital (South Building), Wellington Road, St John's Wood, London NW8 9LE, UK
2Department of Cardiology, Royal Free Hospital, London, UK
3Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands
Received 11 May 2005; revised 30 June 2005; accepted 13 July 2005; online publish-ahead-of-print 8 August 2005.
* Corresponding author. Tel: +44 207 483 5062; fax: +44 207 483 5083. E-mail address: vdanand{at}hotmail.com
Aims Coronary artery disease (CAD) is the leading cause of death in patients with diabetes. Patients often present with advanced and asymptomatic disease. Proposed strategies that may favourably affect CAD risk and outcomes in this patient population include identifying diabetic patients with subclinical disease at high risk of future cardiac events. The purpose of this article was to review the role of both atherosclerosis imaging tests (coronary calcium imaging and high-resolution ultrasound assessment of carotid intima-media thickness) and functional imaging techniques [stress echocardiography and radionuclide myocardial perfusion imaging (MPI)] in the diagnostic and prognostic evaluation of asymptomatic diabetic subjects.
Methods and results We identified studies using MEDLINE searches (1966 to April 2005) and by reviewing reference lists. A comprehensive list of search terms was applied. All stress echocardiography and MPI studies evaluating the prevalence and/or prognostic value of myocardial ischaemia (n=19) and coronary calcium imaging studies (n=2) evaluating the prognostic value of subclinical atherosclerosis in diabetic patients were included.
Conclusion Asymptomatic myocardial ischaemia can be detected in a significant proportion of diabetic subjects by non-invasive imaging tests such as MPI and stress echocardiography. The results of ongoing and future studies may be helpful in guiding the selection of asymptomatic diabetic subjects to undergo non-invasive imaging, establishing the cost-effectiveness of various testing strategies and their impact on prognosis.
Key Words: Diabetes • Coronary artery disease • Atherosclerosis • Non-invasive imaging • Myocardial ischaemia • Coronary calcium
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. Stirrup, K. Wechalekar, A. Maenhout, and C. Anagnostopoulos Cardiac radionuclide imaging in stable coronary artery disease and acute coronary syndromes Br. Med. Bull., March 1, 2009; 89(1): 63 - 78. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. A. Beller Noninvasive Screening for Coronary Atherosclerosis and Silent Ischemia in Asymptomatic Type 2 Diabetic Patients: Is it Appropriate and Cost-Effective? J. Am. Coll. Cardiol., May 15, 2007; 49(19): 1918 - 1923. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Bax, S. E. Inzucchi, R. O. Bonow, J. D. Schuijf, M. R. Freeman, E. J. Barrett, and on behalf of the Global Dialogue Group for the Eva Cardiac Imaging for Risk Stratification in Diabetes Diabetes Care, May 1, 2007; 30(5): 1295 - 1304. [Full Text] [PDF]
|
|
|
|
|
|
J. J. Bax, R. O. Bonow, D. Tschope, S. E. Inzucchi, E. Barrett, and on behalf of the Global Dialogue Group for the Eva The Potential of Myocardial Perfusion Scintigraphy for Risk Stratification of Asymptomatic Patients With Type 2 Diabetes J. Am. Coll. Cardiol., August 15, 2006; 48(4): 754 - 760. [Abstract] [Full Text] [PDF]
|
|